Browse > Article

Inhibition of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Activity by $1,2,3,4,6-Penta-Ο-galloyl-{\beta}-D-glucose$ in Murine Macrophage Cells  

Lee, Sung-Jin (Natural Products Research Institute, College of Pharmacy, Seoul National University)
Lee, Ik-Soo (College of Pharmacy, Chonnam National University)
Mar, Woong-Chon (Natural Products Research Institute, College of Pharmacy, Seoul National University)
Publication Information
Archives of Pharmacal Research / v.26, no.10, 2003 , pp. 832-839 More about this Journal
Abstract
Activated macrophages express inducible isoforms of nitric oxide synthase (iNOS) and cyclooxygenase (COX-2), and produce excessive amounts of nitric oxide (NO) and prostaglandin E$_2$ (PGE$_2$), which play key roles in the processes of inflammation and carcinogenesis. The root of Paeonia lactiflora Pall., and the root cortex of Paeonia suffruticosa Andr., are important Chinese crude drugs used in many traditional prescriptions. 1,2,3,4,6-penta-O-galloyl-$\beta$-D-glucose (PGG) is a major bioactive constituent of both crude drugs. PGG has been shown to possess potent anti-oxidant, anti-mutagenic, anti-proliferative and anti-invasive effects. In this study, we examined the inhibitory effects of 1,2,3,4,6-penta-O-galloyl-$\beta$-D-glucose (PGG) isolated from the root of Paeonia lactiflora Pall. on the COX-2 and iNOS activity in LPS-activated Raw 264.7 cells, COX-1 in HEL cells. To investigate the structure-activity relationships of gallate and gallic acid for the inhibition of iNOS and COX-2 activity, we also examined (-)-epigallocatechin gallate (EGCG), gallic acid, and gallacetophenone. The results of the present study indicated that PGG, EGCG, and gallacetophenone treatment except gallic acid significantly inhibited LPS-induced NO production in LPS-activated macrophages. All of the four compounds significantly inhibited COX-2 activity in LPS-activated macrophages. Among the four compounds examined, PGG revealed the most potent in both iNOS ($IC_{50}$ = 18 $\mu\textrm{g}/mL$) and COX-2 inhibitory activity (PGE$_2$: $IC_{50}$ = 8 $\mu\textrm{g}/mL$ and PGD$_2$: $IC_{50}$ = 12 $\mu\textrm{g}/mL$), respectively. Although further studies are needed to elucidate the molecular mechanisms and structure-activity relationship by which PGG exerts its inhibitory actions, our results suggest that PGG might be a candidate for developing anti-inflammatory and cancer chemopreventive agents.
Keywords
$1,2,3,4,6-Penta-Ο-galloyl-{\beta}-D-glucose$; Inducible nitric oxide synthase; Cyclooxygenase-2, Anti-inflammatory activity;
Citations & Related Records

Times Cited By Web Of Science : 46  (Related Records In Web of Science)
Times Cited By SCOPUS : 51
연도 인용수 순위
1 Alice, H. L., Michael, J. B., and Robert, R. G., Regulation of prostaglandin H systhase mRNA levels and prostaglandin biosynthesis by platelet-derived growth factor. J. Biol. Chem., 264, 17379-17383 (1989)   PUBMED
2 Bhimani, R. S., Troll, W., Grunberger, D., and Frenkel, K., Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Can. Res., 53, 4528-4533 (1993)
3 Cao, Y. and Prescott, S. M., Many actions of cyclooxygenase-2 in cellular dynamics and cancer. J. Cell Physiol., 190, 279-286 (2002)   DOI   ScienceOn
4 Fujiki, H., Yoshizawa, S., Horiuchi, T., Suganuma, M., Yatsunami, J., Nishiwaki, S., Okabe, S., Nishiwaki-Matsushima, R., Okuda, T., and Sugimura, T., Anticarcinogenic effects of (-)-epigallocatechin gallate. Prev. Med., 21, 503-509 (1992)   DOI   ScienceOn
5 Funk, C. D., Prostaglandins and leukotrienes: advances in eicosanoid biology. Science, 294(5548), 1871-1875 (2001)   DOI   PUBMED   ScienceOn
6 Ho., L.-L., Chen, W.-J., Lin-Shiau, S.-Y., and Lin, J.-K., Penta-O-galloyl-beta-D-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1. Eur. J. Pharmacol., 453, 149-158 (2002)   DOI   PUBMED   ScienceOn
7 Inoue, M., Suzuki, R., Koide, T., Sakaguchi, N., Ogihara, Y., and Yabu, Y. Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem. Biophys. Res. Commun., 204, 898-904 (1994)   DOI   ScienceOn
8 Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson P. C., and Moncada, S., Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci., USA, 92, 4392-4396 (1995)   DOI   ScienceOn
9 Morbidelli, L., Chang, C. H., Douglas, J. G., Granger, H. J., Ledda, F., and Ziche, M., Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol., 270, H411-H415 (1996)   DOI   PUBMED
10 Oh, G.-S., Pae, H.-O., Ph, H., Hong, S.-G., Kim, I.-K., Chai, KY., Yun, Y.-G., Kwon, T.-O., and Chung, H.-T., In vitro antiproliferative effect of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose on human hepatocellular carcinoma cell line, SK-HEP-1 cells. Cancer Lett., 174, 17-24 (2001)   DOI   ScienceOn
11 O'Sullivan, M. G., Huggins Jr., E. M., Meade, E. A., DeWitt, D. L., and McCall, C. E., Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem. Biophys. Res. Commun., 187, 1123-1127 (1992)   DOI   ScienceOn
12 Szabo, C., Alterations in nitric oxide production in various forms of circulatory shock. New Hortz., 3, 2-32 (1995)
13 Ziche, M., Morbidelli, L., Masini, E., Amerini, S., Granger, H. J., Maggi, C. A., Geppetti P., and Ledda, F., Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vivo promoted by substance P. J. Clin. Invest., 94, 2036-2044 (1994)   DOI   ScienceOn
14 Liu, R. H. and Hotchkiss, J. H., Potential genotoxicity of chronically elevated nitric oxide: A review. Mutat. Res., 339, 73-89 (1995)   DOI   PUBMED   ScienceOn
15 Tsujii, M., Kawano S., and DuBois, R. N., Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA., 94, 3336-3340 (1997)   DOI   ScienceOn
16 Berg, J., Christoph, T., Widerna, M., and Bodenteich, A., Isoenzyme-specific cyclooxygenase inhibitors: A whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell lin-Mono Mac 6. J. Pharmacol. Toxicol. Methods, 37, 179-186 (1997)   DOI   ScienceOn
17 Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63 (1983)   DOI   PUBMED   ScienceOn
18 Vane, J. R., Bakhle, Y. S., and Botting, R. M., Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol., 38, 97-120 (1998)   DOI   ScienceOn
19 Tunctan, B., Uludag, O., Altug, S., and Abacioglu, N., Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. Pharmacol. Res., 38, 405-411 (1998)   DOI   ScienceOn
20 Katiyar, S. K., Agarwal, R., Zaim, M. T., and Mukhtar, H., Protection against N-nitrosodiethylamine and benzo(a)pyreneinduced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis, 14, 849-855 (1993)   DOI   ScienceOn
21 Sachs, G., Chang, H. H., Ravon, E., Schckman, R., Lewin, M., and Saccomani, G. A., Non electrogenic H+ pump in plasma membranes of hog stomach. J. Biol. Chem., 261, 16788-16791 (1976)
22 Liang, Y. C., Chen, Y. C., Lin, Y. L., Lin-Shiau, S. Y., Ho, C. T., and Lin, J. K., Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate. Carcinogenesis, 20, 733-736 (1999)   DOI   ScienceOn
23 Ono, K., Sawada, T., Murata, Y., Saito, E., Iwasaki, A., Arakawa, Y., Kurokawa, K., and Hashimoto, Y., Pentagalloylglucose, an antisecretory component of Paeoniae radix, inhibits gastric H+, K+-ATPase. Clinica. Chimica. Acta, 290, 159-167 (2000)   DOI   ScienceOn
24 Marletta, M. A., Nitric oxide synthase structure and mechanism. J. Biol. Chem., 268, 12231-12234 (1993)   PUBMED
25 Schmidt, H. H. and Walter, U., NO at work. Cell, 78, 919-925 (1994)   DOI   ScienceOn
26 Xie, W. Q., Kashiwabara, Y., and Nathan, C., Role of transcription factor NFkB/Rel in induction of nitric oxide synthase. J. Biol. Chem., 269, 4705-4708 (1994)   PUBMED
27 Subbaramaiah, K., Telang, N., Ramonetti, J. T., Araki, R., Devito, B., Weksker, B. B., and Dannenberg, A. J., Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res., 56, 4424-4429 (1996)   PUBMED
28 Chin, K., Kurashima, Y., Ogura, T., Tajiri, H., Yoshida, S., and Esumi, H., Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene, 15, 437-442 (1997)   DOI   ScienceOn
29 Dean, A. K., Bradley, S. F., Brian, C. V., Robert, W. L., and Harvey, R. H., TIS 10, a phorbol ester tumor promoterinducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266, 12866-12872 (1991)   PUBMED
30 Ho, C. T., Chen, Q., Shi, H., Zhang, K. Q., and Rosen, R. T., Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prev. Med., 21, 520-525 (1992)   DOI   ScienceOn
31 Pan, M.-H., Lin, J.-H., Lin-Shiau S.-Y and Lin, J.-K., Induction of apoptosis by penta-O-galloyl-beta-D-glucose through activation of caspase-3 in human leukemia HL-60 cells. Eur. J. Pharmacol., 381, 171-183 (1999)   DOI   PUBMED   ScienceOn
32 Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N., Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-716 (1998)   DOI   ScienceOn
33 Amiram, R., Angela, W., Ned, S., and Philip, N., Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J. Bio. Chem., 263, 3022-3024 (1988)
34 Leahy, K. M., Ornberg, R. L., Wang, Y., Zwifel, B. S., Koki, A. T., and Masferrer, J. L., Cyclooxygenase-2 inhibition by celecoxib, reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res., 62, 625-631 (2002)   PUBMED
35 Satoh, K., Nagai, F., Ushiyama, K., Yasuda, I, Seto, T., and Kano, I., Inhibition of Na+, K(+)-ATPase by 1,2,3,4,6-penta-Ogalloyl-beta-D-glucose, a major constituent of both moutan cortex and Paeoniae radix. Biochem. Parmacol., 53, 611-614 (1997)   DOI   ScienceOn
36 Hawkey, C. J., COX-2 inhibitors. Lancet, 353, 307-314 (1999)   DOI   ScienceOn
37 Schlodorff, D., Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int., 44, 643-653 (1993)   DOI   PUBMED   ScienceOn
38 Chen, Y. C., Liang, Y. C., Lin-Shiau, S. Y., Ho, C. Y., and Lin, J. K., Inhibition of TPA-induced PKC and AP-1 binding activities by Theaflavin-3,3'-digallate from black tea in NIH3T3 cells. J. Agric. Food Chem., 367, 379-388 (1999)
39 Lin, Y. L., Juan, I. M., Chen, Y. L., Liang, Y. C., and Lin, J. K., Composition of polyphenols in fresh tea leaves and associations of their oxygen-radical-absorbing capacity with anti proliferative actions in fibroblast cells. J. Agric. Food Chem., 44, 1387-1394 (1996)   DOI   ScienceOn
40 Miyamoto, K., Kishi, N., Koshiura, R., Yoshida, T., Hatano, T., and Okuda, T., Relationship between the structures and the antitumor activities of tannins. Chem. Pharm. Bull., 35, 814-822 (1987)   DOI   PUBMED   ScienceOn
41 Simon, L. S., Role of regulation of cyclooxygenase-2 during inflammation. Am. J. Med., 106, 37S-42S. (1999)   DOI   ScienceOn
42 Lin, Y. L. and Lin J. K., (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-$\kappa$B. Mol. Pharmacol., 52, 465-472 (1997)   DOI   PUBMED